Genomics - The Online Scientific Community

Genomic Sequencing in Clinical Trials
In this article, researchers from Northwestern University Feinberg review the current and future directions of clinical research with respect to genomic sequencing.

Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer
Findings highlight clinical application of next-generation sequencing to suggest targeted therapeutic options for patients.

Transformational Fruit Fly Genome Catalog Completed
Scientists now have a reference manual that should speed gene discoveries in everything from pest control to personalized medicine.

Animal Cell Therapies Announces Cell Inventory Value at $6 Million
The evaluation demonstrates the importance of this first step in the company's mission to improve and extend the lives of dogs through innovative stem cell products and services.

Diffusion Pharmaceuticals Begins Clinical Trial for Treatment of Primary Brain Cancer
Company announced clinical trial testing of its lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.

Drug Halts Organ Damage in Inflammatory Genetic Disorder
NIH study shows benefits of long-term Kineret therapy in people with NOMID.

Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies
Data highlights novel immunomodulatory effects of entinostat in renal and prostate cancer models.

Hunting Could Hurt Genetic Diversity of Sandhill Cranes, UW Research Suggests
Research uses DNA fingerprinting to assess the genetic makeup of cranes.

Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI BioPharma's RNA-Based Therapeutics
AVI BioPharma, Inc. have announced positive safety results from all six dose cohorts in the single ascending dose studies of AVI-6002 and AVI-6003, AVI's lead drug candidates being evaluated for the treatment of Ebola virus and Marburg virus, respectively.

Compugen Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy
Findings support CGEN-15001T's potential as a powerful drug target for cancer immunotherapy.

Cancer Methylome Profiling using Methyl-DNA Capture Dr Arjen Brinkman, Radboud University Nijmegen (NL), speaking at Next-Gen Sequencing Europe 2011.
A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.
RNA-Seq for High Throughput Clinical Studies Wenzhong Xiao, Assistant Professor of Bioinformatics, Massachusetts General Hospital, speaking at Next-Gen Sequencing Congress 2011.
Genome-scale Quantitative Tumour Proteomics for Cancer Biomarkers Discovery Metodi Metodiev, Lecturer/Director of Proteomics Unit, University of Essex, speaking at European Biomarkers Summit 2011.
Single Cell Genomics: Accessing the Genomes of Uncultivated Microbes Mary-Jane Lombardo, Research Scientist, J. Craig Venter Institute, speaking at Next-Gen Sequencing Congress 2011.
Genomics of Bacterial Pathogen Strain Variation Timothy Read, Associate Professor, Emory University School of Medicine, speaking at Next-Gen Sequencing Congress 2011.
Using Next-Gen Sequencing to Uncover Patterns of Allele-Specific Expression Sergio Baranzini, Associate Professor, University of California, San Francisco, speaking at Epigenetics World Congress 2011.
The Epigenetic Regulation of microRNA Genes and Their Role in Cell Invasion and Motility in Human Melanomas Ranjan Perera, Associate Professor, Sandford Burnham Medical Research Institute, Speaking at Epigenetics World Congress 2011
Capturing Ephemeral Hemimethylation at CpG and non-CpG Cytosines: Insights From Molecules and Math Diane Genereux, Post Doctoral Associate, Department of Biology, University of Washington, speaking at Epigenetics World Congress 2011.
Pharmacogenomics of Drug Disposition: From Polymorphisms to Biomarkers Urs A. Meyer, Emeritus Professor, Biozentrum, University of Basel speaking at ADMET Europe 2011

<<	1 2 3 4 5 6 7	>>
Showing Results 1 - 10 of 110